2364 related articles for article (PubMed ID: 7915815)
1. Characterization of effector cells against B16 melanoma in mice inoculated with allogeneic spleen cells.
Nishi Y; Hosokawa T; Aoike A; Han D; Takehara H; Kawai K; Kamahora T
Microbiol Immunol; 1994; 38(3):217-23. PubMed ID: 7915815
[TBL] [Abstract][Full Text] [Related]
2. Early development of CD8-negative and CD8-positive MHC-unrestricted cytotoxic cells induced by alloantigen inoculation in mice.
Nishi Y; Hosokawa T; Aoike A; Kawai K; Kamahora T
Microbiol Immunol; 1990; 34(9):775-85. PubMed ID: 2126592
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
Nakagawa R; Nagafune I; Tazunoki Y; Ehara H; Tomura H; Iijima R; Motoki K; Kamishohara M; Seki S
J Immunol; 2001 Jun; 166(11):6578-84. PubMed ID: 11359810
[TBL] [Abstract][Full Text] [Related]
4. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
Suzuki R; Suzuki S; Ebina N; Kumagai K
J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
[TBL] [Abstract][Full Text] [Related]
5. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
Yang H; Yogeeswaran G; Bukowski JF; Welsh RM
Nat Immun Cell Growth Regul; 1985; 4(1):21-39. PubMed ID: 3875791
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of killer activity of murine spleen cells against allogeneic and syngeneic tumor cells by inoculation of alloantigen in vivo.
Nishi Y; Hosokawa T; Aoike A; Kamahora T; Sudo H; Kawai K
Microbiol Immunol; 1987; 31(12):1245-54. PubMed ID: 2453782
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
8. Natural cell-mediated cytotoxicity (NCMC) against NK-sensitive tumours in vitro by murine spleen Ly-6C+ natural T cells.
Martiniello R; Burton RC; Smart YC
Int J Cancer; 1997 Feb; 70(4):450-60. PubMed ID: 9033654
[TBL] [Abstract][Full Text] [Related]
9. Ly-6C+ natural T (NT) cells mediate immune surveillance against NK-sensitive and NK-resistant transplantable tumours in certain strains of mice.
Martiniello R; Burton RC; Smart YC
Int J Cancer; 1996 May; 66(4):532-7. PubMed ID: 8635870
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of cultured mouse spleen cells against natural killer-sensitive target cells. Characterization of the effector cells.
Oshimi K; Kano S; Sumiya M; Gonda N; Takaku F
Int Arch Allergy Appl Immunol; 1981; 64(4):395-409. PubMed ID: 6451584
[TBL] [Abstract][Full Text] [Related]
11. Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents.
Saijo N; Ozaki A; Beppu Y; Takahashi K; Fujita J; Sasaki Y; Nomori H; Kimata M; Shimizu E; Hoshi A
J Cancer Res Clin Oncol; 1984; 107(3):157-63. PubMed ID: 6736102
[TBL] [Abstract][Full Text] [Related]
12. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
[TBL] [Abstract][Full Text] [Related]
13. In vivo requirement for asialo GM1 and Thy1 positive leukocytes for antitumor effect of rIL-2 +/- rIFN-gamma.
Silagi S; Dutkowski R; Schaefer A
Anticancer Res; 1988; 8(6):1265-9. PubMed ID: 2905882
[TBL] [Abstract][Full Text] [Related]
14. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
Yoshioka T; Sato S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
[TBL] [Abstract][Full Text] [Related]
15. Role of natural killer cells in the mechanism of the antitumor effect of interferon on Moloney sarcoma virus-transformed cells.
Fresa KL; Murasko DM
Cancer Res; 1986 Jan; 46(1):81-8. PubMed ID: 3940213
[TBL] [Abstract][Full Text] [Related]
16. Autolymphocyte therapy. II. Dependence of in vivo anti-tumor specificity and long-term immunity against murine melanoma and carcinoma on ex vivo activated donor memory T-cells.
Gold JE; Osband ME
Clin Immunol Immunopathol; 1994 Jun; 71(3):325-32. PubMed ID: 7911078
[TBL] [Abstract][Full Text] [Related]
17. Asialo-GM1-positive T killer cells are generated in F1 mice injected with parental spleen cells.
Knobloch C; Dennert G
J Immunol; 1988 Feb; 140(3):744-9. PubMed ID: 2448375
[TBL] [Abstract][Full Text] [Related]
18. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells.
Fujiwara H; Qian JH; Satoh S; Kokudo S; Ikegami R; Hamaoka T
J Immunol; 1986 Apr; 136(8):2763-8. PubMed ID: 2420865
[TBL] [Abstract][Full Text] [Related]
19. The cytolytic activity of natural killer cells is not involved in the restriction of Mycobacterium avium growth.
Flórido M; Correia-Neves M; Cooper AM; Appelberg R
Int Immunol; 2003 Aug; 15(8):895-901. PubMed ID: 12882827
[TBL] [Abstract][Full Text] [Related]
20. Presence of T cell-associated surface antigens on murine NK cells.
Pollack SB; Tam MR; Nowinski RC; Emmons SL
J Immunol; 1979 Oct; 123(4):1818-21. PubMed ID: 314475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
